---
title: 'High prevalence of pancreatic steatosis in pancreatic cancer patients: A meta-analysis
  and systematic review'
date: '2024-12-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39706752/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241221170703&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: PDAC patients have a high prevalence of PS, and they are
  significantly more likely to have PS compared to controls. These findings emphasize
  the need to prioritize a standardized approach to the diagnosis, follow-up, and
  treatment of PS, with future studies focusing on identifying patients who would
  benefit from PDAC surveillance ...'
disable_comments: true
---
CONCLUSIONS: PDAC patients have a high prevalence of PS, and they are significantly more likely to have PS compared to controls. These findings emphasize the need to prioritize a standardized approach to the diagnosis, follow-up, and treatment of PS, with future studies focusing on identifying patients who would benefit from PDAC surveillance ...